Skip to main content
Signal8

Murray Dallan

SEC insider (Form 3/4/5 filer). CIK 0002022303. Chief Customer Officer at Sarepta Therapeutics, Inc. (SRPT). 10 reported Form 4/5 transactions since Sep 2024; latest on Mar 10, 2025. Located in CAMBRIDGE, MA.

Companies Murray Dallan has filed insider reports for

  • Sarepta Therapeutics, Inc. (SRPT): Officer, Chief Customer Officer
Murray Dallan profile photo

Murray Dallan

CIK: 0002022303

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (20.0%)

Derivative conversions

Awards (A)2 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)6 (60.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Sarepta Therapeutics, Inc. logo
SRPT

Sarepta Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 10, 2025
    Tax Payment
    Direct
    996 shares at avg. $100.13$100K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 10, 2025
    Tax Payment
    Direct
    2.7K shares at avg. $100.13$274K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 10, 2025
    Award
    Direct
    8.3K shares-
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 7, 2025
    Exercise
    Direct
    5.5K shares-
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 7, 2025
    Tax Payment
    Direct
    549 shares at avg. $103.70$57K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 7, 2025
    Tax Payment
    Direct
    8.6K shares at avg. $103.70$893K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 6, 2025
    Exercise
    Direct
    17.5K shares-
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 4, 2025
    Tax Payment
    Direct
    1.7K shares at avg. $101.34$171K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Mar 3, 2025
    Tax Payment
    Direct
    711 shares at avg. $103.77$74K
  • Sarepta Therapeutics, Inc. logo
    SRPT

    Sarepta Therapeutics, Inc.

    Feb 11, 2025
    Award

    Performance Restricted Stock Units

    Direct
    3.5K shares-

1-10 of 10